Description

Collagen Type I N-telopeptide is released during bone resorption into the serum, and it is then excreted in the urine. The concentration of the peptide correlates with the rate of bone resorption.


 

Specimens: urine or serum

 

Units of measurement: BCE/L (where BCE = bone collagen equivalent)

 

Reference: upper limit of normal for young adult

 

patient's NTx value as percent of normal young adult =

= (patient's NTx value) / (upper limit of normal reference range for young adult) * 100%

 

change in NTx with therapy =

= ((NTx before therapy) - (NTx after therapy)) / (NTx before therapy) * 100%

 

General rules:

(1) In most cases of postmenopausal or age-related osteoporosis the levels of NTx are not greatly increased (no more than 2 times the upper limit of a young adult). A higher concentration may indicate either osteomalacia or a more aggressive form of osteoporosis.

(2) If the osteoporosis is due to a correctable cause, then the NTx levels should return to the normal range if it has been successfully treated.

(3) The goal of therapy in age-related or post-menopausal osteoporosis is to reduce the concentration of NTx by 50 to 60% of the pretreatment level within 3-6 months of starting therapy.

 

Limitations:

• The assay has a relatively large coefficient of variation.

• Bone resorption varies during the day, so a change in the time of specimen collection may reflect physiologic change rather than response to therapy.

 


To read more or access our algorithms and calculators, please log in or register.